# FDA Inspection 1023992 - Department of Defense - Navy - August 17, 2017

Source: https://www.keypedia.com/records/fda_inspections/department-of-defense-navy/13762a1e-0b70-46ce-a064-37dc3fafa637
Source feed: FDA_Inspections

> FDA Inspection 1023992 for Department of Defense - Navy on August 17, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1023992
- Company Name: Department of Defense - Navy
- Inspection Date: 2017-08-17
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1276508 - 2025-07-11](https://www.keypedia.com/records/fda_inspections/department-of-defense-navy/f1249f2d-5bad-4b3d-87c3-f6f7f4a76527)
- [FDA Inspection 1276508 - 2025-07-11](https://www.keypedia.com/records/fda_inspections/department-of-defense-navy/d0c15940-7f67-4104-8a41-8ce6aa1db406)
- [FDA Inspection 940237 - 2015-08-20](https://www.keypedia.com/records/fda_inspections/department-of-defense-navy/ba245bf8-91ce-4370-8f03-61f7522fb623)
- [FDA Inspection 849447 - 2013-09-24](https://www.keypedia.com/records/fda_inspections/department-of-defense-navy/ca4883c6-d58f-4341-840a-0507cbea9e7d)
- [FDA Inspection 696628 - 2010-10-28](https://www.keypedia.com/records/fda_inspections/department-of-defense-navy/6646d3c6-a507-4002-82a0-212bd7ef6f4e)

Company: https://www.keypedia.com/companies/department-of-defense-navy/51423087-2e2a-40d2-938d-70170300f0c1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d